Fomivirsen
From Wikipedia, the free encyclopedia
Image:Fomivirsen.png | |
Fomivirsen
|
|
Systematic (IUPAC) name | |
? | |
Identifiers | |
CAS number | 160369-77-7 |
ATC code | S01AD08 |
PubChem | ? |
Chemical data | |
Formula | ? |
Mol. weight | ? |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
B2 |
Legal status | |
Routes | ? |
Fomivirsen (brand name "Vitravene") is an antiviral drug. It is used in the treatment of cytomegalovirus retinitis (CMV) in immunocompromised patients, including those with AIDS.
It is an oligonucleotide that blocks transcription of viral mRNA by bindng to a coding segment of a key CMV gene. It was the first antisense antiviral approved by the FDA.
[edit] See also
[edit] External links
- Diagram
- MedlinePlus DrugInfo uspdi-203675
- DDB 31313
- (2001) "Fomivirsen.". Drugs Today (Barc) 37 (4): 245-255. PMID 12768225.
- Geary R, Henry S, Grillone L (2002). "Fomivirsen: clinical pharmacology and potential drug interactions.". Clin Pharmacokinet 41 (4): 255-60. PMID 11978144.
- (2002) "Randomized dose-comparison studies of intravitreous fomivirsen for treatment of cytomegalovirus retinitis that has reactivated or is persistently active despite other therapies in patients with AIDS.". Am J Ophthalmol 133 (4): 475-83. PMID 11931781.
- Roehr B (1998). "Fomivirsen approved for CMV retinitis.". J Int Assoc Physicians AIDS Care 4 (10): 14-6. PMID 11365956.
Antivirals (primarily J05A, also S01AD and D06BB) edit | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|